Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study.

被引：0
|
作者：
Saito, K. [1 ]
Uchida, K. [2 ]
Takahara, S. [3 ]
Yoshimura, N. [4 ]
Teraoka, S. [5 ]
Cornu-Artis, C. [6 ]
Kobayashi, E. [7 ]
Takahashi, K. [1 ]
机构：
[1] Niigata Univ, Niigata, Japan
[2] Aichi Med Univ, Aichi, Japan
[3] Osaka Univ, Osaka, Japan
[4] Kyoto Prefectural Univ Med, Kyoto, Japan
[5] Int Univ Hlth & Welf, Atami Hosp, Shizuoka, Japan
[6] Novartis Pharma AG, Basel, Switzerland
[7] Jichi Med Univ, Shimotsuke, Tochigi, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：314 / 314
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED-EXPOSURE CYCLOSPORINE IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH ANALYSIS FROM THE TRANSFORM STUDY
    Sommerer, Claudia
    Pinchuk, Aleksey
    Aleman, Silvina
    Vuiblet, Vincent
    Van der Giet
    Amante, Angel Joaquin
    Han, Duck Jong
    Huynh-Do, Uyen
    Ingsathit, Atiporn
    Gawai, Apurva
    Gutierrez, Maria Pilar Hernandez
    Carmellini, Mario
    TRANSPLANTATION, 2020, 104 (09) : S622 - S623
  • [2] 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
    Tedesco-Silva, Helio, Jr.
    Vitko, Stefan
    Pascual, Julio
    Eris, Josette
    Magee, John C.
    Whelchel, John
    Civati, Giovanni
    Campbell, Scott
    Alves-Filho, Gentil
    Bourbigot, Bernard
    Garcia, Valter Duro
    Leone, John
    Esmeraldo, Ronaldo
    Rigotti, Paolo
    Cambi, Vincenzo
    Haas, Tomas
    TRANSPLANT INTERNATIONAL, 2007, 20 (01) : 27 - 36
  • [3] Efficacy and Safety of Everolimus in De Novo Liver Transplant Recipients-12 Month Results of a Randomized, Multicenter Study.
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    LIVER TRANSPLANTATION, 2012, 18 : S109 - S110
  • [4] Concentration-Controlled Everolimus with Reduced Cyclosporine Concentration in Japanese De Novo Renal Transplant Recipients: Efficacy and Safety Results at 12 Months: Japanese Multicenter Study
    Yoshimura, N.
    Uchida, K.
    Takahara, S.
    Teraoka, S.
    Kobayashi, E.
    Teshima, R.
    Cornu-Artis, C.
    Takahashi, K.
    TRANSPLANTATION, 2012, 94 (10) : 990 - 990
  • [5] Impact on Wound Healing Events After Early Conversion to Everolimus in De Novo Renal Transplant Recipients: 24-Month Results from the Randomized ELEVATE Study.
    Nashan, B.
    van der Giet, M.
    Holdaas, H.
    Zeier, M.
    Pascual, J.
    Avihingsanon, Y.
    Lopez, P.
    Aguilar-Sanchez, J.
    Kochuparampil, J.
    Wang, Z.
    Cruzado, J.
    De Fijter, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 534 - 534
  • [6] Antirejection Efficacy in De Novo Renal Transplant Recipients Receiving Everolimus with a Reduced-Exposure Calcineurin Inhibitor-Based Regimen: 24-Month Results from the TRANSFORM Study.
    Silva, H. Tedesco
    Citterio, F.
    Henry, M.
    Srinivas, T. R.
    Watarai, Y.
    Steinberg, S.
    Basic-Jukic, N.
    Garcia, V. D.
    Mor, E.
    Peddi, V. R.
    Narvekar, P.
    Gutierrez, M. P. Hernandez
    Bernhardt, P.
    Pascual, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 358 - 359
  • [7] EFFICACY AND SAFETY OF 24 MONTHS IMMUNOSUPPRESSION WITH CONCENTRATION-CONTROLLED EVEROLIMUS AND REDUCED CYCLOSPORINE IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Yaqoob, M.
    Riad, H.
    Pattison, J.
    Cornu-Artis, C.
    Wang, Z.
    Tedesco Silva, H.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 39 - 39
  • [8] Effect of Induction Therapy on Outcomes of De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from the TRANSFORM Study.
    Oberbauer, R.
    Vincenti, F.
    Viklicky, O.
    Huynh-Do, U.
    Kim, D.
    Cruzado, J. M.
    Qazi, Y.
    Kim, M. S.
    Narvekar, P.
    Gutierrez, M. P. Hernandez
    Bernhardt, P.
    Kuypers, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 558 - 558
  • [9] 24-Month Safety and Efficacy of Concentration Controlled Everolimus with Reduced Cyclosporine Versus Mycophenolate Mofetil in 721 De Novo Heart Transplant Recipients: Results from the A2310 Study
    Epailly, E.
    Eisen, H.
    Pauly, D.
    Hirt, S.
    Lehmkuhl, H.
    Andreassen, A.
    Rinaldi, M.
    Yonan, N.
    Potena, L.
    Zuckermann, A.
    Dong, G.
    Panis, C.
    Lopez, P.
    Kobashigawa, J.
    TRANSPLANTATION, 2012, 94 (10) : 127 - 127
  • [10] Pharmacokinetics of Everolimus When Combined With Cyclosporine in Japanese De Novo Renal Transplant Recipients
    Uchida, K.
    Hoshinaga, K.
    Watarai, Y.
    Goto, N.
    Kusaka, M.
    Sasaki, H.
    Hirano, M.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (05) : 1314 - 1318
12345